Sign up to our newsletter Subscribe
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

Medicines aim to cure diseases, or at least relieve symptoms, to enable longer, healthier and more productive lives. Access to appropriate medicines, used sustainably, has substantial benefits for community health and related economic indicators.